Key Takeaways
- • Premji Invest and A91 Partners are among private equity investors in talks to acquire a stake in Shreeji Imaging and Diagnostic Centre, according to DealStreetAsia.
- • The source material reports the investor interest but does not disclose the stake size, transaction value, or valuation.
- • The process is described as a competitive race, indicating multiple PE bidders are evaluating the diagnostics provider.
Summary
The report does not disclose the size of the stake under discussion, the proposed transaction value, or any valuation metrics for Shreeji Imaging. Nor does it specify whether the transaction would involve a primary issuance, a secondary sale by existing shareholders, or a combination of both. Timing of any definitive agreement is also not addressed.
Premji Invest, the investment vehicle associated with the Premji family, and A91 Partners, an Indian private equity firm, are both active in the country's healthcare and growth-stage investment landscape. Their participation signals continued institutional interest in Indian healthcare services, particularly diagnostics, which has attracted sustained private capital in recent years. Readers should treat the reported talks as preliminary until a definitive transaction is announced.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.